These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2623740

  • 1. Evaluation of prognostic features in thymic epithelial tumors.
    Kirchner T, Schalke B, Marx A, Müller-Hermelink HK.
    Thymus; 1989; 14(1-3):195-203. PubMed ID: 2623740
    [Abstract] [Full Text] [Related]

  • 2. Thymomas and thymic carcinomas. A retrospective investigation with histological reclassification.
    Engel P, Pilsgaard B, Francis D.
    APMIS; 1995 Sep; 103(9):671-8. PubMed ID: 7488389
    [Abstract] [Full Text] [Related]

  • 3. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK, Marx A.
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [Abstract] [Full Text] [Related]

  • 4. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B, Rudnicka L, Dubiel-Bigaj M, Malinowski E.
    Pol J Pathol; 1998 Oct; 49(4):251-65. PubMed ID: 10323079
    [Abstract] [Full Text] [Related]

  • 5. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL.
    Cancer; 1994 Jul 15; 74(2):606-17. PubMed ID: 8033040
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thymomas and thymic carcinomas.
    Walker AN, Mills SE, Fechner RE.
    Semin Diagn Pathol; 1990 Nov 15; 7(4):250-65. PubMed ID: 2284513
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H, Eimoto T, Tada T, Inagaki H, Hattori H, Takino H.
    Mod Pathol; 1997 Oct 15; 10(10):983-91. PubMed ID: 9346177
    [Abstract] [Full Text] [Related]

  • 10. DNA-ploidy analysis correlates with the histogenetic classification of thymic epithelial tumours.
    Gschwendtner A, Fend F, Hoffmann Y, Krugmann J, Klingler PJ, Mairinger T.
    J Pathol; 1999 Dec 15; 189(4):576-80. PubMed ID: 10629561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C, Rajagopal P, Rakshak AD, Omprakash G, Das SM, Murthy JM.
    Indian J Pathol Microbiol; 2003 Jul 15; 46(3):378-81. PubMed ID: 15025278
    [Abstract] [Full Text] [Related]

  • 13. Histopatholgical spectrum of thymic neoplasms: twelve-year experience at a referral hospital in north India.
    Radotra B, Awasthi A, Joshi K, Das A.
    Indian J Pathol Microbiol; 2006 Jan 15; 49(1):1-6. PubMed ID: 16625962
    [Abstract] [Full Text] [Related]

  • 14. [B-cells in thymic epithelial tumors: phenotype, distribution and relation to the intramedullary B-cell population of the normal thymus].
    Fend F, Kirchner T, Marx A, Müller-Hermelink HK.
    Verh Dtsch Ges Pathol; 1992 Jan 15; 76():253-5. PubMed ID: 1283270
    [Abstract] [Full Text] [Related]

  • 15. [Surgical therapy for patients with thymoma or thymic carcinoma; based on WHO classification].
    Yoneda S, Matsuzoe D, Kawahara K, Shirakusa T.
    Kyobu Geka; 2002 Oct 15; 55(11):926-30. PubMed ID: 12391687
    [Abstract] [Full Text] [Related]

  • 16. B-cells in thymic epithelial tumours. An immunohistochemical analysis of intra- and extraepithelial B-cell compartments.
    Fend F, Kirchner T, Marx A, Müller-Hermelink HK.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993 Oct 15; 63(4):241-7. PubMed ID: 7685134
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H, Tateyama H, Tada T, Saito Y, Yamakawa Y, Eimoto T.
    Virchows Arch; 2000 Jan 15; 436(1):20-7. PubMed ID: 10664158
    [Abstract] [Full Text] [Related]

  • 20. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L, Wilkins EW, Ferry JA, Harris NL.
    Hum Pathol; 1993 Sep 15; 24(9):958-69. PubMed ID: 8253462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.